@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ns1: <http://purl.org/spar/pro/> .
@prefix ns2: <http://prismstandard.org/namespaces/basic/2.0/> .
@prefix ns3: <http://purl.org/spar/datacite/> .
@prefix ns4: <http://purl.org/vocab/frbr/core#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<> dcterms:license <https://creativecommons.org/publicdomain/zero/1.0/legalcode> .

<https://w3id.org/oc/meta/br/06190510231> a <http://purl.org/spar/fabio/Expression>,
        <http://purl.org/spar/fabio/JournalArticle> ;
    rdfs:label "br 06190510231" ;
    ns2:publicationDate "2018-10"^^xsd:gYearMonth ;
    dcterms:title "The Expression Of Cannabinoid Type 1 Receptor And 2-Arachidonoyl Glycerol Synthesizing/Degrading Enzymes Is Altered In Basal Ganglia During The Active Phase Of Levodopa-Induced Dyskinesia" ;
    ns3:hasIdentifier <https://w3id.org/oc/meta/id/06190568703>,
        <https://w3id.org/oc/meta/id/062304078346>,
        <https://w3id.org/oc/meta/id/06730104548> ;
    ns1:isDocumentContextFor <https://w3id.org/oc/meta/ar/061902000296>,
        <https://w3id.org/oc/meta/ar/061902000297>,
        <https://w3id.org/oc/meta/ar/061902000298>,
        <https://w3id.org/oc/meta/ar/061902000299>,
        <https://w3id.org/oc/meta/ar/061902000300>,
        <https://w3id.org/oc/meta/ar/061902000301>,
        <https://w3id.org/oc/meta/ar/061902000302>,
        <https://w3id.org/oc/meta/ar/061902000303>,
        <https://w3id.org/oc/meta/ar/061902000304> ;
    ns4:embodiment <https://w3id.org/oc/meta/re/06190348760> ;
    ns4:partOf <https://w3id.org/oc/meta/br/06190511083> .

